The Venture Codex Logo

The Venture Codex

Overview

Surgical oncology company revolutionizing musculoskeletal cancer treatment.

Total Raised

$75 M

Rounds

5

Links

Verticals

Health Care
Medical
Medical Device
Oncology
Pharmaceutical

Investment History

  1. Debt Financing

    Jan 2025

    $35M

  2. Series C

    Sep 2021

    $15M

  3. Equity

    Apr 2020

    $8M

  4. Series B

    Apr 2017

    $18M

Team

Patrick Treacy

Co Founder & CEO

Antony Koblish

Co-Founder

Gordon Ballard

Vice President, Operations

Bradly Tyler

Sr. Vice President Finance and Administration